Continental Stock Transfer & Trust CompanyShare Escrow Agreement • May 23rd, 2016 • CB Pharma Acquisition Corp. • Blank checks
AGREEMENTInvestment Agreement • May 23rd, 2016 • CB Pharma Acquisition Corp. • Blank checks • New York
THIS AGREEMENT (this “Agreement”) is dated as of May 20, 2016 by and among Fortress Biotech, Inc. (“Fortress”), Adam J. Chill (“Chill”), Arthur A. Kornbluth (“Kornbluth”), Neil Herskowitz (“Herskowitz”), EJF Opportunities, LLC (“EJF”), Stephen B. Pudles (“Pudles”), Jose M. Aldeanueva (“Aldeanueva”), Jeffrey J. Gutovich Profit Sharing Plan (“GPSP”) and Barry Rodgers (“Rodgers”) and CB Pharma Acquisition Corp., a Cayman Islands company (the “Company”). Fortress, Chill, Kornbluth and Herskowitz are each herein referred to individually as a “Seller” and collectively as the “Sellers”. EJF, Pudles, Aldeanueva, GPSP and Rodgers are each herein referred to individually as an “Investor” and collectively as the “Investors”.
CB Pharma Acquisition Corp.Registration Rights Agreement • May 23rd, 2016 • CB Pharma Acquisition Corp. • Blank checks
May 20, 2016Voting Agreement • May 23rd, 2016 • CB Pharma Acquisition Corp. • Blank checks • New York
As a condition to the consummation of the transactions contemplated by that certain agreement (the “Transfer Agreement”), dated the date hereof, by and among the undersigned, CB Pharma Acquisition Corp. (the “Company”), Fortress Biotech, Inc., Adam J. Chill, Arthur A. Kornbluth and Neil Herskowitz (collectively, the “Sellers”), the undersigned hereby agrees as follows (certain capitalized terms used herein are defined in paragraph 13 hereof):.
CB Pharma Acquisition Corp.Letter Agreement • May 23rd, 2016 • CB Pharma Acquisition Corp. • Blank checks
CB Pharma Acquisition Corp.Insider Letter Agreement • May 23rd, 2016 • CB Pharma Acquisition Corp. • Blank checks
TERMINATIONTermination Agreement • May 23rd, 2016 • CB Pharma Acquisition Corp. • Blank checks
Reference is made to the letter agreement, dated as of December 12, 2014 (the “Agreement”), between CB Pharma Acquisition Corp. (the “Company”) and Fortress Biotech, Inc. (formerly Coronado Biosciences, Inc.) (the “Admin Provider”).
